BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16404862)

  • 1. [The course of chronic glomerulonephritis in chronic opisthorchiasis].
    Beloborodova EI; Zibnitskaia LI; Kaliuzhina EV
    Ter Arkh; 2005; 77(11):44-9. PubMed ID: 16404862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the filtration function of the kidneys during the treatment of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Kozlov VV; Kucher AG
    Ter Arkh; 1994; 66(8):52-7. PubMed ID: 7985156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome].
    Duman VL
    Ter Arkh; 2002; 74(6):39-41. PubMed ID: 12136481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of the clinical course and dynamics of the morphological changes in chronic glomerulonephritis].
    Tov NL; Valentik MF; Vlazneva VA; Kagalovskaia IM; Nesina IA
    Ter Arkh; 1986; 58(8):10-3. PubMed ID: 3764748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of dehelminthization on pancreatic incretory and excretory functions in patients with psoriasis concurrent with chronic opisthorchiasis].
    Savkina KA; Khardikova SA; Kaliuzhina MI
    Med Parazitol (Mosk); 2007; (4):16-9. PubMed ID: 18277417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous "pulse" cyclophosphamide therapy of crescentic glomerulonephritis.
    Kunis CL; Kiss B; Williams G; D'Agati V; Appel GB
    Clin Nephrol; 1992 Jan; 37(1):1-7. PubMed ID: 1541058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prediction of accelerated progression of chronic glomerulonephritis basing on clinical and histomorphological data].
    Ratner MIa; Stenina II; Fedorova ND
    Ter Arkh; 1999; 71(6):27-30. PubMed ID: 10420451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic glomerulonephritis using indomethacin and small doses of cyclophosphamide].
    Vanrenteghem Y; Roels L; Verberckmoes R; Michielsen P
    J Urol Nephrol (Paris); 1975; 81(4-5):281-90. PubMed ID: 1159887
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic glomerulonephritis with cytostatics].
    Tareeva IE; Gordovskaia NB; Gladskikh OP; Ivanov AA; Krasnova TN
    Ter Arkh; 1989; 61(6):9-14. PubMed ID: 2799726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morpho-clinical variants of chronic glomerulonephritis and their significance for the evaluation of the severity of the disease].
    Ratner MIa; Gel'fand IM; Varshavskiĭ VA; Rozenfel'd BI; Brodskiĭ MA
    Arkh Patol; 1984; 46(11):46-52. PubMed ID: 6525063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring of the clinical and morphological course of glomerulonephritis].
    Pap I; Kemnitz P; Willgeroth Ch
    Z Urol Nephrol; 1978 Jun; 71(6):369-74. PubMed ID: 685514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
    Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors influencing the results of chronic glomerulonephritis treatment].
    Riabov SI; Stavskaia VV; Chistova EK; Ashkinazi RI; Zaitseva NI; Kravchenko NP; Mozgovaia AN; Sashurina SN
    Klin Med (Mosk); 1997; 75(2):38-42. PubMed ID: 9157214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical varieties of chronic glomerulonephritis and psychic characteristics of patients].
    Palamarchuk MI; Kukhtevich AV; Sokolova ED
    Ter Arkh; 2002; 74(6):49-52. PubMed ID: 12136484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic enzyme therapy in chronic glomerulonephritis].
    Siniachenko OV; Kovalenko VN; Mukhin IV; Ignatenko GA; Terzov AI
    Ter Arkh; 2000; 72(2):46-8. PubMed ID: 10717926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclophosphamide efficacy in maintenance therapy of nephrotic syndrome in patients with chronic glomerulonephritis].
    Ter Arkh; 2004; 76(9):26-8. PubMed ID: 15532372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension in chronic glomerulonephritis: detectability and treatment efficacy].
    Kutyrina IM; Martynov SA; Shvetsov MIu; Lifshits NL; Miroshnichenko NG; Golitsina EP; Varshavskiĭ VA
    Ter Arkh; 2004; 76(9):10-5. PubMed ID: 15532369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific features of a course of chronic glomerulonephritis with onset in childhood].
    Shishkin AN; Makarova IuA; Erman MV
    Ter Arkh; 2007; 79(6):52-6. PubMed ID: 17684968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colonic involvement in chronic opisthorchiasis].
    Beloborodova EI; Repnikova RV
    Med Parazitol (Mosk); 2004; (3):32-5. PubMed ID: 15484978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.